CAGRILINTIDE 1MG + TIRZEPATIDE 10MG – 11MG VIAL | HUDSON SCIENCE

This cutting-edge blend of Cagrilintide (1MG) and Tirzepatide (10MG) delivers next-level appetite regulation, weight loss acceleration, and metabolic enhancement in a single 11MG research vial. Combining Tirzepatide’s dual action on GLP-1 and GIP receptors with Cagrilintide’s amylin receptor agonism, this synergistic compound mimics multiple natural satiety and energy regulation hormones—unlocking one of the most powerful formulations for body recomposition and advanced metabolic control.

Ideal for researchers and individuals seeking aggressive fat loss support, this combo is designed to dramatically suppress appetite, stabilize blood glucose, and promote significant weight reduction, while protecting lean mass.

Each lyophilized vial contains:

• 10MG Tirzepatide – Dual GLP-1 + GIP agonist
• 1MG Cagrilintide – Long-acting amylin mimetic
• Total: 11MG of synergistic, research-grade peptide power

For more advanced peptide combinations and fat-loss solutions, visit: True North Performance